Home/Shanton Pharma/Carmen Arencibia

CA

Carmen Arencibia

Director of Clinical Operations

Therapeutic Areas

Gout Hyperuricemia Pruritus

Shanton Pharma Pipeline

Drug	Indication	Phase
SAP-001	Refractory/Tophaceous Gout	Phase 2

Leadership Team at Shanton Pharma

Chief Executive Officer

Wenfeng Miao, M.D., Ph.D.

Chief Medical Officer

Pieter de Ridder, MBA

VP of Business Development

Shanshan Cui, Ph.D.

VP of Clinical Development

View full Shanton Pharma profile